You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Patients in UK get early access to GSK’s Jemperli

GSK has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a positive opinion, under the Early Access to Medicines Scheme (EAMS), for the use of its anti-PD-1 therapy Jemperli.